Article Details

Pfizer Confirms US Patent Term Extension for IBRANCE® (palbociclib) Until March 2027

Retrieved on: 2021-02-05 11:48:45

Tags for this article:

Click the tags to see associated articles and topics

Pfizer Confirms US Patent Term Extension for IBRANCE® (palbociclib) Until March 2027. View article details on hiswai:

Excerpt

NEW YORK--(BUSINESS WIRE)--Feb 5, 2021--. Pfizer Inc. (NYSE: PFE) today announced that the U.S. Patent and Trademark Office (USPTO) recently ...

Article found on: www.galvnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up